Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2007
12/25/2007US7311920 Virus coat protein/receptor chimeras and methods of use
12/25/2007US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response
12/25/2007US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007US7311916 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
12/25/2007US7311915 peptide mixture; induce immunology response; gag protein; vaccines
12/25/2007US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy
12/25/2007US7311910 Inhibiting interaction of CTLA4(Cytotoxic T-Lymphocyte Antigen 4)positive T cells with B7-1 or B7-2 positive cells by contacting with an antibody or antibody fragment which recognizes and binds an extracellular domain; tissue transplant rejection; graft versus host disease
12/25/2007US7311909 PRO4348 antibodies
12/25/2007US7311903 Recombinant cytokine for use in treatment of viral infection and cell proliferative disorders
12/25/2007US7311902 Conjugates comprising human IL-18 and substitution mutants thereof
12/21/2007WO2007147159A2 Functional nucleic acid ligands to fluorescent proteins
12/21/2007WO2007147096A2 A family of pesticidal proteins and methods for their use
12/21/2007WO2007146980A2 Improved epsp synthases: compositions and methods of use
12/21/2007WO2007146968A2 Single-chain multivalent binding proteins with effector function
12/21/2007WO2007146959A2 Pan-cell surface receptor- specific therapeutics
12/21/2007WO2007146689A2 Stabilized insulin-like growth factor polypeptides
12/21/2007WO2007146269A2 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/21/2007WO2007146171A2 Purified high molecular weight adiponectin and uses thereof
12/21/2007WO2007146163A2 Fc-fusion proteins with reduced fc-mediated effector activities
12/21/2007WO2007145467A1 A novel gene from hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same
12/21/2007WO2007145318A1 Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same
12/21/2007WO2007145192A1 Collagen type iv-like immunoreactive peptide
12/21/2007WO2007144685A1 Cd4 mimic peptides and their uses
12/21/2007WO2007144492A2 Peptides with anti-proliferative activity
12/21/2007WO2007144475A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
12/21/2007WO2007144442A1 P53 fusion proteins without transcription activity, and applications thereof
12/21/2007WO2007144140A1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof
12/21/2007WO2007143858A1 Dph2 gene deletion mutant and uses thereof
12/21/2007WO2007124750A3 Methods for isolation and analysis of sialylated and phosphorylated peptides
12/21/2007WO2007124115A3 Compositions and methods for identifying inhibitors and activators of cyclic amp phosphodiesterases
12/21/2007WO2007123839A3 Peptides with efficacy in rescuing melanocortin-4 receptor polymorphic agonist signaling
12/21/2007WO2007118751A3 Method for modifying the atp/adp ratio in cells
12/21/2007WO2007116278A3 Antiangiogenic peptide and therapeutic uses thereof
12/21/2007WO2007109651A3 Selective growth of stable polymorphs
12/21/2007WO2007107597A3 Immunogenic construct and a method for the prophylactic or therapeutic treatment of aids
12/21/2007WO2007102812A3 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells
12/21/2007WO2007101274A3 Mycobacterial disease detection, treatment, and drug discovery
12/21/2007WO2007101146A3 Selective vpac2 receptor peptide agonists
12/21/2007WO2007096187A3 Computer gene
12/21/2007WO2007093962A3 Method for producing terpenes and mep-transformed microorganisms therefore
12/21/2007WO2007093177A3 Metallothionein-derived peptide fragments
12/21/2007WO2007090967A3 Peptide domain required for interaction between the envelope of a virus pertaining to the herv-w interference group and an hasct receptor
12/21/2007WO2007087851A3 Method for producing epitomers and their uses on carrier microorganisms
12/21/2007WO2007082264A3 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
12/21/2007WO2007078239A3 Spider silk proteins and methods for producing spider silk proteins
12/21/2007WO2007071699A3 Methods for screening therapeutic efficacy of compositions in treatment of bone disease
12/21/2007WO2007071454A3 Dendritic cell specific transcription regulator dc-script and uses thereof
12/21/2007WO2007064997A3 Compounds and methods for inhibiting apoptosis
12/21/2007WO2007056540A3 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
12/21/2007WO2007005647A3 Polynucleotides and polypeptides of the il-12 family of cytokines
12/21/2007WO2006134148A3 Transglutaminase mediated conjugation of growth hormone
12/21/2007WO2006099592A3 Mannose immunogens for hiv-1
12/21/2007WO2006037383A8 Piscirickettsia salmonis antigens and use thereof
12/21/2007WO2005123110A3 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof
12/21/2007WO2005023193A3 Methods of treating endometriosis
12/21/2007WO2004069848A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007WO2004069178A3 Anti-inflammatory activity from lactic acid bacteria
12/21/2007WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007CA2657949A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
12/21/2007CA2657948A1 Denatured collagen peptides and uses thereof
12/21/2007CA2656077A1 A process for the preparation of poly-alpha-glutamic acid and derivatives thereof
12/21/2007CA2655565A1 Dph2 gene deletion mutant and uses thereof
12/21/2007CA2655371A1 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
12/21/2007CA2655361A1 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
12/21/2007CA2655205A1 Pan-cell surface receptor- specific therapeutics
12/21/2007CA2655116A1 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/21/2007CA2654956A1 Peptides with anti-proliferative activity
12/21/2007CA2654944A1 Stabilized insulin-like growth factor polypeptides
12/21/2007CA2654840A1 Biomolecule-linked biomimetic scaffolds
12/21/2007CA2654701A1 Cholesterol-regulating complex of sirt1 and lxr and methods of use
12/21/2007CA2654552A1 Rationale, methods, and assays for identifying novel taste cell genes and salty taste receptor targets and assays using these identified genes or gene products
12/21/2007CA2654100A1 Use of nac transcription factor for enchancing yield-related traits in plants
12/21/2007CA2654055A1 Albumin fusion proteins
12/21/2007CA2652872A1 Use of a plastid-lipid associated protein promoter (pap promoter) for heterologous gene expression
12/21/2007CA2651962A1 Anthrax compositions and methods of use and production
12/20/2007US20070294788 Transposable Elements in Rice and Methods of Use
12/20/2007US20070293663 modified oligonucleotide consisting of 12 to 30 linked nucleosides for modulating the expression of signal transducer and activator of transcription (STAT) proteins
12/20/2007US20070293659 Immobilization of glycoproteins
12/20/2007US20070293658 Process For The Purification Of Il-18 Binding Protein
12/20/2007US20070293657 Complexes and methods of forming complexes of ribonucleic acids and peptides
12/20/2007US20070293656 Collagen binding peptides
12/20/2007US20070293655 Supercritical fluids processing: preparation of protein microparticles and their stabilisation
12/20/2007US20070293453 Combinatorial Methods For Inducing Cancer Cell Death
12/20/2007US20070293450 Identification of ses-3 and the uses of same
12/20/2007US20070293448 Synthetic gagpol genes and their uses
12/20/2007US20070293434 Binding polypeptides and methods based thereon
12/20/2007US20070293431 Method for improving neurotransmission failure using a novel agent
12/20/2007US20070293430 Mutein of human FGF-21 containing an engineered disulfide where cysteine replaces leucine 118 and alanine 134, alanine for serine 167; reduced deamidation and capacity of O-glycosylation compared to wild-type human FGF-21; antidiabetic agents, type 2 diabetes; obesity; metabolic syndrome
12/20/2007US20070293429 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity
12/20/2007US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof
12/20/2007US20070293424 Antitumoral and Antiviral Peptides
12/20/2007US20070293422 Beta-Amyloid Inhibitors and Use Thereof
12/20/2007US20070293420 Enrichment of erythropoietin from a culture supernatant produced by culturing eukaryotic host cells followed by at least 5 chromatographic purification steps
12/20/2007US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007US20070292953 Disarmed Agrobacterium Strains, Ri-Plasmids, and Methods of Transformation Based Thereon
12/20/2007US20070292948 Obtained by introducing modified embryonic stem cells into early stage embryo, then implanting the manipulated embryo into surrogate mother; transfection; deletions, tumor suppressor genes; induction of oncogene following administration of tetracycline analog results in development of tumor
12/20/2007US20070292947 Novgel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
12/20/2007US20070292944 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors
12/20/2007US20070292921 tRNA synthetases, metRS
12/20/2007US20070292920 Neurotoxins with enhanced target specificity
1 ... 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 ... 2916